AirBridgeCargo Airlines ships vaccine candidate for clinical trials

In September, the cargo carrier completed the complex transport of 12 SkyCell containers from Hong Kong to Amsterdam. (Source: AirBridgeCargo)

AirBridgeCargo Airlines successfully delivered CanSinoBIO‘s Covid-19 vaccine candidate in partnership with UPS/Marken. This marked its first completed vaccine transportation from Beijing (China) to an unmentioned destination as part of clinical trials in various countries across the globe.

Also read: Volga-Dnepr Group introduces healthcare team to lead vaccine distribution

The carrier’s Boeing 747 freighter carried a total of 6,000 doses of the Ad5-nCoV vaccine, weighing almost 400 kilograms, packed into a CRЗDO™ XTREME a passive container, stacked and loaded into a standard AKE container and delivered under 2°C to 8°C.

“After months of preparations, we are actually stepping into the COVID-19 vaccine transportation phase to deliver these sophisticated pharmaceutical products the whole world relies on as a source which will help all of us to get back to normal,” said Casper Pan, vaccine task force lead and APAC head of healthcare for Volga-Dnepr Group.

Yulia Celetaria, healthcare director of Volga-Dnepr Group, thanked UPS for ensuring vaccine efficacy was fully maintained throughout the journey. “We hope for further cooperation through our joint shipments, workshops and follow-up online meetings,” she added.